Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Tumor immune microenvironment"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Article image
Immune landscape and biomarkers for immuno-oncology in colorectal cancers
Jeong Mo Bae, Seung-Yeon Yoo, Jung Ho Kim, Gyeong Hoon Kang
J Pathol Transl Med. 2020;54(5):351-360.   Published online June 26, 2020
DOI: https://doi.org/10.4132/jptm.2020.05.15
  • 6,575 View
  • 310 Download
  • 10 Web of Science
  • 11 Crossref
AbstractAbstract PDF
Recent advances in immuno-oncology have increased understanding of the tumor immune microenvironment (TIME), and clinical trials for immune checkpoint inhibitor treatment have shown remission and/or durable response in certain proportions of patients stratified by predictive biomarkers. The TIME in colorectal cancer (CRC) was initially evaluated several decades ago. The prognostic value of the immune response to tumors, including tumor-infiltrating lymphocytes, peritumoral lymphoid reaction, and Crohn’s-like lymphoid reaction, has been well demonstrated. In this review, we describe the chronology of TIME research and review the up-to-date high-dimensional TIME landscape of CRC. We also summarize the clinical relevance of several biomarkers associated with immunotherapy in CRC, such as microsatellite instability, tumor mutational burden, POLE/POLD mutation, consensus molecular subtype, and programmed death-ligand 1 expression.

Citations

Citations to this article as recorded by  
  • Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy
    Yiwei Zhang, Yujun Zhang, Jingjing Song, Xifu Cheng, Chulin Zhou, Shuo Huang, Wentao Zhao, Zhen Zong, Lingling Yang
    International Immunopharmacology.2024; 131: 111876.     CrossRef
  • Five decades of colorectal cancer pathology: The World and China
    Maode Lai
    Chinese Science Bulletin.2024;[Epub]     CrossRef
  • T cell receptor clonotype in tumor microenvironment contributes to intratumoral signaling network in patients with colorectal cancer
    In Hye Song, Seung-been Lee, Byung-Kwan Jeong, Jungwook Park, Honggeun Kim, GunHee Lee, Su Min Cha, Heejae Lee, Gyungyub Gong, Nak-Jung Kwon, Hee Jin Lee
    Immunologic Research.2024; 72(5): 921.     CrossRef
  • Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis
    Kaimin Guo, Jinna Yang, Ruonan Jiang, Xiaxia Ren, Peng Liu, Wenjia Wang, Shuiping Zhou, Xiaoguang Wang, Li Ma, Yunhui Hu
    Pharmaceuticals.2024; 17(10): 1295.     CrossRef
  • Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study
    Ippokratis Messaritakis, Eleni Psaroudaki, Konstantinos Vogiatzoglou, Maria Sfakianaki, Pantelis Topalis, Ioannis Iliopoulos, Dimitrios Mavroudis, John Tsiaoussis, Nikolaos Gouvas, Maria Tzardi, John Souglakos
    Cancers.2023; 15(19): 4819.     CrossRef
  • Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
    Moonsik Kim, Ji Yun Jeong, An Na Seo
    Diagnostics.2023; 13(17): 2782.     CrossRef
  • Evaluation on Braking Stability of Autonomous Vehicles Running along Curved Sections Based on Asphalt Pavement Adhesion Properties
    Binshuang Zheng, Xiaoming Huang, Junyao Tang, Jiaying Chen, Runmin Zhao, Zhengqiang Hong, Tao Tang, Meiling Han, Yang Yang
    Journal of Advanced Transportation.2022; 2022: 1.     CrossRef
  • Intratumoral spatial heterogeneity of tumor-infiltrating lymphocytes is a significant factor for precisely stratifying prognostic immune subgroups of microsatellite instability-high colorectal carcinomas
    Minsun Jung, Ji Ae Lee, Seung-Yeon Yoo, Jeong Mo Bae, Gyeong Hoon Kang, Jung Ho Kim
    Modern Pathology.2022; 35(12): 2011.     CrossRef
  • Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
    Marina Vitorino, Inês Eiriz, Tiago C Tomás, Rodrigo Vicente, Ana Mendes, Ana Rita Freitas, Sofia Braga, Catarina Alves-Vale, Paula Borralho, André Ferreira, Luisa Leal da Costa
    Cureus.2022;[Epub]     CrossRef
  • Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Yan Li, Yiqi Ma, Zijun Wu, Fanxin Zeng, Bin Song, Yanrong Zhang, Jinxing Li, Su Lui, Min Wu
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers
    Jung Ho Kim, Mi-Kyoung Seo, Ji Ae Lee, Seung-Yeon Yoo, Hyeon Jeong Oh, Hyundeok Kang, Nam-Yun Cho, Jeong Mo Bae, Gyeong Hoon Kang, Sangwoo Kim
    Journal for ImmunoTherapy of Cancer.2021; 9(12): e003414.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP